Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01182155 · ClinicalTrials.gov registry record
Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 20
- Enrollment target
NCT01182155: Completed study, sponsored by Stanford University.
NCT01182155 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01182155 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Patients treated with radiation therapy for lung tumors can experience inflammation after treatment. This study hopes to evaluate the use of breath analysis to evaluate changes in the composition of exhaled breath in patients undergoing radiotherapy. If changes can be detected, this may ultimately serve as biomarkers for identifying patients at highest risk for radiation-induced lung injury (radiation pneumonitis).
Interventions
- PROCEDURE Exhaled Breath Sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-03 |
What the finished NCT01182155 record still lists
NCT01182155 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Exhaled Breath Sampling is the first listed.
NCT01182155 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01182155 about?
NCT01182155 is a clinical study titled "Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation". Patients treated with radiation therapy for lung tumors can experience inflammation after treatment. This study hopes to evaluate the use of breath analysis to evaluate changes in the composition of exhaled breath in patients undergoing radiotherapy. If changes can be detected, this may ultimately s...
What is the current status of trial NCT01182155?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-08. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01182155?
The interventions under investigation include: Exhaled Breath Sampling (PROCEDURE).
Who is sponsoring clinical trial NCT01182155?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia